CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Arven Ilac Sanayi Ve Ticaret against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 7, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Pharmaceutical Formulations Comprising 4-{(1R)-2- [(6-{2-[(2,6-Dichlorobenzyl)Oxy] Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2- (Hydroxymethyl)PhenolGLAXO GROUPFeb 14, 2020

Explore Arven Ilac Sanayi Ve Ticaret's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Sep 2, 2020Dry Powder Inhaler Compositions Comprising Long Acting Muscorinic Antagonists3
Jan 22, 2020Vilanterol Formulations3
Jan 15, 2020Dry Powder Formulations Comprising Vilanterol4
Sep 12, 2018A Process For The Preparation Of Formulations For Inhalation1

Top competitors of Arven Ilac Sanayi Ve Ticaret

List of top competitors of Arven Ilac Sanayi Ve Ticaret based on patent oppositions.